CSIMarket
 


Perkinelmer Inc  (PKI)
Other Ticker:  
 

Cumulative Perkinelmer Inc's Total Debt to Equity for Trailing Twelve Months Period

PKI's Total Debt to Equity for Trailing Twelve Months Period and Total Debt, Equity growth


Select the Comparisons : Select the Ratio:

PKI Total Debt to Equity for Trailing Twelve Months Period

(Apr 02 2023)
I. Quarter
(Jan 01 2023)
IV. Quarter
(Oct 02 2022)
III. Quarter
(Jul 03 2022)
II. Quarter
(Apr 03 2022)
I. Quarter
Y / Y Equity Growth 11.79 % 4.5 % 1.53 % 69.04 % 79.56 %
Y / Y Total Debt Growth -10.42 % -0.27 % -13.75 % 90.74 % 88.81 %
Total Debt to Equity for Trailing Twelve Months Period 0.6 0.63 0.64 0.66 0.66
Total Ranking # 2446 # 2430 # # #
Seq. Equity Growth 8.82 % 4.5 % -1.42 % -0.27 % 1.71 %
Seq. Total Debt Growth -0.77 % -0.17 % -1.93 % -7.79 % 10.48 %


Total Debt to Equity for Trailing Twelve Months Period Comment for 12 Months ending at Apr 02 2023
On the trailing twelve months basis Due to repayements of liabilities of -0.77% Perkinelmer Inc decreased Total Debt to Equity for Trailing Twelve Months Period in the I. Quarter to 0.6, above Perkinelmer Inc's average Total Debt to Equity for Trailing Twelve Months Period.
Total Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Laboratory Analytical Instruments industry 15 other companies have achieved lower Total Debt to Equity for Trailing Twelve Months Period than Perkinelmer Inc. While total ranking remained unchanged compare to previous quarter at no. .

What is Debt to Equity Ratio?
PKI Charts and Quotes
Total Debt to Equity PKI in the most recent quarter
Total Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 16
Sector # 416
S&P 500 # 2181


Total Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0.66 0.35 0
(Jul 03 2022)   (Sep. 30, 2015)




Companies with similar average Total Debt to Equity for Trailing Twelve Months Period for 12 months ending Apr 02 2023, within Laboratory Analytical Instruments Industry Total Debt to Equity for Trailing Twelve Months Period
Avantor Inc   1.38 
Pacific Biosciences Of California Inc   1.34 
Bruker Corporation  1.12 
Htg Molecular Diagnostics Inc  1.08 
Akoya Biosciences Inc   0.68 
Harvard Bioscience Inc  0.63 
Thermogenesis Holdings Inc   0.63 
Perkinelmer Inc  0.61 
Agilent Technologies inc   0.53 
Isoplexis Corporation  0.53 
Eyepoint Pharmaceuticals Inc   0.31 
Codex Dna Inc   0.31 
Lifeloc Technologies Inc   0.21 
Illumina Inc   0.20 
Phenomex Inc   0.19 
Bio rad Laboratories Inc   0.12 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com